PAR 2.00% 24.5¢ paradigm biopharmaceuticals limited..

Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-67

  1. 1,798 Posts.
    lightbulb Created with Sketch. 648
    Thats because the pill form have adverse affects to get the required dose for OA dmoad. Thats why injectable form is being researched in the first place. Do some research, its all there.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.005(2.00%)
Mkt cap ! $85.70M
Open High Low Value Volume
25.0¢ 25.5¢ 24.0¢ $187.1K 755.0K

Buyers (Bids)

No. Vol. Price($)
2 47906 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 13363 1
View Market Depth
Last trade - 16.10pm 11/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.